Vaxcyte PCVX
NASDAQ PCVX
$68.62 +2.26 (+3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Vaxcyte (PCVX) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Vaxcyte (PCVX) reported Net Equity Issued and Repurchased of $7.32 million for Q3 2026, compared with $306,000 a year earlier and down 5.7% from the prior quarter.

Analysis

Vaxcyte (PCVX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Vaxcyte's Net Equity Issued and Repurchased came in at $27.53 million, up 77.0% year-over-year; for FY2025, it was $13.01 million, down 94.2% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -34.9% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $223.09 million in FY2024 (+126.7%), $98.39 million in FY2023 (-4.7%), $103.23 million in FY2022 (+480.1%) and $17.8 million in FY2021 (-84.0%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $306,000 in Q3 2025 and a high of $110.91 million in Q2 2024.
  • Year over year, Net Equity Issued and Repurchased gained in four of the last seven quarters, with growth averaging 9.4%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2022 (growth of 597.5%); the low point was Q3 2025 (a decline of 99.7%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $7.76 million (Q2 2026), $9.03 million (Q1 2026) and $3.42 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vaxcyte 9.91 Bn 3.83 Bn - 7.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 7.32 Mn
Jun 30, 2026 7.76 Mn
Mar 31, 2026 9.03 Mn
Dec 31, 2025 3.42 Mn
Sep 30, 2025 306,000.00
Jun 30, 2025 3.24 Mn
Mar 31, 2025 6.05 Mn
Dec 31, 2024 5.96 Mn
Sep 30, 2024 101.20 Mn
Jun 30, 2024 110.91 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 3.04 Mn
Sep 30, 2023 51.16 Mn
Jun 30, 2023 1.90 Mn
Mar 31, 2023 42.29 Mn
Dec 31, 2022 5.08 Mn
Sep 30, 2022 44.88 Mn
Jun 30, 2022 49.88 Mn
Mar 31, 2022 3.40 Mn
Dec 31, 2021 8.75 Mn
API Access

Vaxcyte Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PCVX&period=max&api_key=YOUR_API_KEY